Pune India, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the structural heart devices market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the structural heart devices market are present across various countries in the above-mentioned regions.
Get Sample Copy of This Report @ https://greyviews.com/reports/structural-heart-devices-market/467/request-sample
The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as the indication, product type, procedure, and regions. Apart from this, the key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the below paragraphs.
The significant players operating in the global structural heart devices market are Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, Abbott Laboratories, ST. JUDE MEDICAL, Biomerics, Comed BV, LivaNova PLC, JenaValve Technology Inc., and CardioKinetix. among others. To achieve a substantial market share in the worldwide structural heart devices market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.
In structural heart disease, patients suffering from both congenital and acquired heart disease can undergo extensive percutaneous treatments. A cardiac chamber, proximal great vessels and heart valves that have structural and functional abnormalities can be seen from birth, but they may also occur later in life because of infection wear and tear. Compared to open-heart operations, structural cardiac procedures and devices are less intrusive, which makes them highly desired. To treat structural heart disorders, cardiologists routinely perform minimally invasive procedures to replace the aortic, mitral, and artificial heart valves. Devices for the heart include balloons for occlating the heart valve and annuloplasty rings for tightening the ring around the heart if it is oversized or leaky. Due to the global epidemic of cardiovascular diseases, demand for heart valve devices is on the rise, which is expected to drive market growth. In the past few decades, structural heart devices have improved their function through the advancement of technology, and improved treatments have contributed to a higher standard of living and longer life expectancy. Due to the minimally invasive nature of structural heart surgery, it is often preferred over traditional open-heart procedures. There are some factors which are hampering the growth of the market such as high costs and stringent regulatory guidelines.
Enquiry Before Buying This Report @ https://greyviews.com/inquiry/467
Scope of Structural Heart Devices Market Report:
| Report Metric | Information |
| Study Period | 2022-2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Market Share Unit | USD Billion |
| Segments Covered | Indication, Product Type, Procedure, and Regions. |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle-East and Africa |
| Major Players | Boston Scientific Corporation, Medtronic, Edwards Lifesciences Corporation, Abbott Laboratories, ST. JUDE MEDICAL, Biomerics, Comed BV, LivaNova PLC, JenaValve Technology Inc., and CardioKinetix. among others |
Segmentation Analysis
Aortic valvular disease is expected to be the fastest-growing segment in 2022.
The indication segment is divided into atrial septal defects, aortic valvular disease, pulmonary valvular disease, patent foramen ovale, ventricular septal defects, mitral valvular disease, patent ductus arteriosus, and others. The aortic valvular disease segment is expected to witness the highest growth rate during the forecast period. There is a connection between aortic valvular disease and the aorta, since the aorta carries oxygenated blood from the heart to the body, and when there is aortic valvular disease, the aorta does not fully open. In order to treat it, a structural cardiac device is implanted through minimally invasive surgical techniques. Therefore, the indication section will be dominated by aortic valvular disease.
Heart valve devices are expected to be the fastest-growing segment in 2022.
The product type segment is divided into heart valve devices, annuloplasty rings, occluders and delivery systems, transcatheter mitral valve repair, and others. The heart valve devices segment is expected to witness the highest growth rate during the forecast period. It is a one-way valve implanted into the heart as a replacement for a heart valve that does not function properly. A mechanical heart valve, a bioprosthetic tissue valve or an engineered tissue valve are three broad categories of artificial heart valves.
Replacement is expected to be the fastest-growing segment in 2022.
The procedure segment is divided into repair and replacements. The replacement segment is expected to witness the highest growth rate during the forecast period. As a result of the development of superior, flexible, sophisticated, resilient, and highly effective structural cardiac devices, the need for replacement has increased. A successful long-term alternative to repair methods is a replacement, which increases blood flow and makes the patient live a longer life.
Regional Analysis
The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for the structural heart devices market include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia.
The North American region witnessed a major share. Structural heart devices have been a major success in North America due to a large pool of patients, favourable reimbursement scenarios, and advanced healthcare infrastructure. Although minimally invasive surgery such as transcatheter aortic valve implantation (TAVI) and mitral valve repair/replacement may reduce utilization rates over the forecast period, increasing penetration may result in lower utilization rates.
Country Analysis
- Germany
Germany's structural heart devices market size was valued at USD 0.92 billion in 2022 and is expected to reach USD 2.18 billion by 2030, at a CAGR of 11.4% from 2023 to 2030.
In Germany, the market is expanding due to an increase in surgeries, cardiovascular illnesses, and advanced treatment methods.
- China
China’s structural heart devices market size was valued at USD 0.98 billion in 2022 and is expected to reach USD 2.37 billion by 2030, at a CAGR of 11.7% from 2023 to 2030.
As awareness of cardiac disease increases, neonatal screening programs improve, and access to healthcare expands in China, the market is expected to expand.
- India
India's structural heart devices market size was valued at USD 0.76 billion in 2022 and is expected to reach USD 1.8 billion by 2030, at a CAGR of 11.6% from 2023 to 2030.
Increasing healthcare facility demand, a favourable reimbursement environment, and an increase in structural heart disease awareness drive the market for structural heart devices in the country.
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.
Furthermore, the growth of this market is mainly driven owing to the rising demand for flavored beverages among consumers, propelling the growth of the market across the countries.
Buy Now Full Report @ https://greyviews.com/checkout/467/single_user_license
Contact Us
Rocky Shah
GreyViews
Pune India
Phone: (+44) 162-237-1047
Email: sales@greyviews.com
Browse Related Reports:
Veterinary Hematology Analyzers Market Size By Product Type (Table Top Analyzers (Fully Automatic Analyzers and Semiautomatic Analyzers) and Point of Care Analyzers (Cartridge-Based Analyzers and Direct Sample Based Analyzers), By Analysis Parameter (2-Part WBC Differential, 3-Part WBC Differential, 5-Part WBC Differential, and Others), By End-User (Research institutes, Veterinary hospitals and clinics, Veterinary diagnostic centers, point-of-care testing, inhouse-testing, and others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/veterinary-hematology-analyzers-market/469
Structural Heart Devices Market Size By Indication (Atrial Septal Defects, Aortic Valvular Disease, Pulmonary Valvular Disease, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Valvular Disease, Patent Ductus Arteriosus, and Others), By Product Type (Heart Valve Devices, Annuloplasty Rings, Occluders and Delivery Systems, Transcatheter Mitral Valve Repair, and Others), By Procedure(Repair and Replacements), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/structural-heart-devices-market/467
Shoulder Arthroplasty Market Size By Indication (Arthritis, Fracture/Dislocation, Rotator Cuff Tear Arthropathy, Hill Sachs Defect, and Others), By Device (Shoulder Arthroplasty Resurfacing Implants, Shoulder Arthroplasty Trauma Devices, and Shoulder Arthroplasty Platform Systems), By Procedure (Partial Shoulder Arthroplasty, Total Shoulder Arthroplasty, Reverse Shoulder Arthroplasty, and Revision Shoulder Arthroplasty), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/shoulder-arthroplasty-market/466
Radiopharmaceuticals Market Size By Procedural Volume (Diagnostic Producers and Therapeutic Procedures), By Application (Endocrinology, Oncology, Neurology, Cardiology, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/radiopharmaceuticals-market/465
Intrathecal Pumps Market Size By Type (Morphine, Baclofen, Ziconotide, Clonidine, Bupivacaine, and Others), By Application (Pain and Spasticity), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/intrathecal-pumps-market/462
Injection Molding Market Size By Material (Metals, Plastics, and Others), By Technology (Electric, Hydraulic, and Hybrid), By Application (Building & Construction, Packaging, Medical, Consumables & Electronics, Automotive & Transportation, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/injection-molding-market/461
Influenza Diagnostics Market Size By Test Type (Cell Culture, RIDT, RT-PCR and Others), By End-User (Diagnostic Laboratories, Clinics, Hospitals and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/influenza-diagnostics-market/460
Intrathecal Pumps Market Size By Type (Morphine, Baclofen, Ziconotide, Clonidine, Bupivacaine, and Others), By Application (Pain and Spasticity), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/hemato-oncology-testing-market/458
Embolotherapy Market Size By Disease (Oncology, Peripheral Vascular Diseases and Others), By Embolic Agents (Liquid Embolic Agent, Microspheres, Embolic Coils, Detachable Balloons and Others), By End-User (Ambulatory Surgery Centres, Hospitals & Clinics and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/embolotherapy-market/453
Embolization Coils Market Size By Type (Pushable Coil and Detachable Coil), By Application (Urology, Cardiology, Oncology, Neurology, and Others), By Material (Platinum Tungsten Alloy, Platinum and Platinum & Hydrogel), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/embolization-coils-market/452
